Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jieni Yu"'
Hub genes and associated drugs for multiple myeloma with 1q21+: identified by bioinformatic analysis
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
While 1q21+ was common genetic alteration and found to have adverse effect on prognosis, the underlying genes remain unclear. Identification of related genes may provide additional help for rational intervention. The microarray dataset GSE2658 associ
Externí odkaz:
https://doaj.org/article/6f69e59b3c2b4eb58867206dae686547
Autor:
Leihua Fu, Jieni Yu, Zhe Chen, Feidan Gao, Zhijian Zhang, Jiaping Fu, Weiying Feng, Pan Hong, Jing Jin
Publikováno v:
Infectious Agents and Cancer, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Background Epidemiological research and systematic meta-analyses indicate a higher risk of B-cell lymphomas in patients with chronic hepatitis C virus (HCV) compared to non-infected individuals. However, the genetic links between HCV and the
Externí odkaz:
https://doaj.org/article/cf500497467442a3ad562223dcf59b1f
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 575-582 (2022)
Purpose Multiple myeloma is still an incurable disease In the past decade, with the continuous progress of treatment methods, the progression-free survival of patients has been prolonged, but some patients still progress in the early stage of the dis
Externí odkaz:
https://doaj.org/article/78097b418aa14d20afa08651e8991c9b
Autor:
Jieni Yu, Zhiqiang Xu, Yuanyuan Zhuo, Huahua Wei, Yinhai Ye, Qinhong Xu, Youli Li, Lihong Yu, Weiying Feng, Pan Hong, Kejie Zhang
Publikováno v:
Hematology (Amsterdam, Netherlands). 26(1)
Corticosteroid is first-line therapy in immune thrombocytopenia. However, nearly 30% of patients appear in steroid-resistance. Our research analyses the relevant indicators of patients and develops a risk prediction model to predict the poor response
Publikováno v:
Medicine. 100(48)
Acute promyelocytic leukemia (APL) is one of the most curable cancers. However, relapse of the disease is a difficult issue in clinical practice and it remains a great challenge that patients have a poor effect of conventional treatment in the clinic
Publikováno v:
Medicine. 98:e16246
Rationale Fusarium is the second most common cause of fungi infections in the immunocompromised patients with the mortality rate over 80%. Early identification and appropriate selection of antifungal drugs is the key to successful treatment. Patient